FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to medicine and pharmaceutics, namely to a method for preventing disturbance of intercellular contacts of endotheliocytes. Method involves administering lithium chloride in a certain concentration into a monolayer of endothelial cells of the Ea.hy 926 line 1 hour before toxic exposure to human blood serum.
EFFECT: invention provides preventing intercellular contacts of endotheliocytes required for correcting endothelial dysfunction in patients with critical conditions accompanied by a systemic inflammatory response by administering LiCl before exposure to a pathogenic factor.
1 cl, 13 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF ENDOTHELIAL DYSFUNCTION | 2017 |
|
RU2657416C1 |
| METHOD FOR EVALUATING LYMPHOCYTE EFFECT ON DEVELOPING ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2482487C2 |
| PEPTIDE THAT IMPROVES THE FUNCTIONAL PROPERTIES OF THE VASCULAR ENDOTHELIUM, A PHARMACEUTICAL COMPOSITION BASED ON IT AND THE METHOD FOR ITS APPLICATION | 2021 |
|
RU2769051C1 |
| WAY OF CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2007 |
|
RU2359686C2 |
| METHOD OF PREVENTING ENDOTHELIAL DAMAGE IN CRITICALLY ILL PATIENTS | 2023 |
|
RU2812594C1 |
| METHOD FOR PLURIPOTENT STEM CELLS DIFFERENTIATION INTO VASCULAR BED CELLS | 2012 |
|
RU2618871C2 |
| METHOD OF EVALUATION OF DEGREE OF ENDOTHELIAL DYSFUNCTION | 2007 |
|
RU2324939C1 |
| THERAPEUTIC APPLICATION OF NEW PHARMACEUTICAL PREPARATIONS CONTAINING ANTINEOPLASTIC DRUGS, ASSOCIATED WITH HYALURONIC ACID, IN TREATING NEOPLASMS | 2009 |
|
RU2581972C2 |
| METHOD FOR DETERMINING DIAGNOSTIC CRITERION OF VASCULAR WALL STIFFNESS IN PATIENTS SUFFERING ARTERIAL HYPERTENSION ACCOMPANIED BY ABDOMINAL OBESITY | 2014 |
|
RU2567606C1 |
| METHOD OF INHIBITION OF INTERCELLULAR ADHESION AND METHOD OF INHIBITION OF INFLAMMATORY PROCESS | 1996 |
|
RU2179021C2 |
